日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models

利用体外试验和鼠模型,对胰高血糖素抑制剂与肝脏优先胰岛素联合治疗糖尿病的临床前研究进行了探索。

Hvid, Henning; Brand, Christian L; Hummelshøj, Tina; Jensen, Sanne; Bouman, Stephan D; Bowler, Andrew; Poulsen, Bjarne R; Tiainen, Peter; Åkertröm, Thorbjörn; Demozay, Damien; Hoeg-Jensen, Thomas; Ingvorsen, Camilla; Pedersen, Thomas Å; McGuire, Jim; Egebjerg, Thomas; Cappelen, Karen A; Eliasen, Ina P; Hansen, Bo F; Hennen, Stephanie; Stidsen, Carsten E; Olsen, Grith S; Roed, Nikolaj K

A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome

预防晚期动脉粥样硬化和降低代谢综合征小鼠模型血糖的新策略

Jenny E Kanter, Farah Kramer, Shelley Barnhart, Jeffrey M Duggan, Masami Shimizu-Albergine, Vishal Kothari, Alan Chait, Stephan D Bouman, Jessica A Hamerman, Bo F Hansen, Grith S Olsen, Karin E Bornfeldt